October 13, 2011
- The contraceptive pill Yasmin
- Biological methods of contraception
- Silest, reviews about the drug
- Pulmonary thromboembolism
The US Agency FDA, is engaged in the control of medicines and food, actively explores
konratseptivnye funds
. According to the organization, preparations to protect against unwanted pregnancy, which comprise a part of the substance
Drospirenone
Can be dangerous because of the risk of
blood clots
. However, with the final conclusions of the FDA is not in a hurry because of too contradictory results of the research.
The results of two recent studies are still being analyzed by experts, and the original data still indicate an increased risk of blood clots and a half times those women who take oral contraceptives containing drospirenone compared with women using similar tools, but without this component.
Given the variety of research data, the organization still has been studying this problem. On December 8 of this year, is scheduled to meet members of the media, which are associated with health human reproductive system and the Committee on drug safety drug use, which resulted in the conclusions will be drawn about the possibility of further use of such means of contraception. However, to date, FDA warned that women who are at risk of developing blood clots, you may want to give up this kind of means of protection.